نتائج البحث - "Zanete Zvirbule"

1

Abstract 2172: Tumor IL1RAP levels and reduction in serum biomarkers correlate with response in PDAC patients treated with nadunolimab, an anti-IL1RAP monoclonal antibody, in combination with gemcitabine and nab-paclitaxel

المؤلفون: Eric Van Cutsem, Joelle Collignon, Rikke Eefsen, Sebastian Ochsenreither, Zanete Zvirbule, Audrius Ivanauskas, Camilla Rydberg Millrud, Petter Skoog, Nedjad Losic, Susanne Magnusson, Annika Sanfridson, David Liberg

المصدر: Cancer Research. 83:2172-2172

مصطلحات موضوعية: Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a3a1351b3e5149afae682f8050682f70
https://doi.org/10.1158/1538-7445.am2023-2172

2

Results of a Dose‐Finding Phase 1b Study of Subcutaneous Atezolizumab in Patients With Locally Advanced or Metastatic Non–Small Cell Lung Cancer

المؤلفون: Zanete Zvirbule, Marion Monchalin, Nadia Tosti, Kunihiko Tanaka, Emanuela Pozzi, Eleonora Restuccia, Pascal Chanu, Enriqueta Felip, Vidya Maiya, Phyllis Chan, Bei Wang, Luis A. Herráez-Baranda, Smita Kshirsagar, Mathilde Marchand, Mauricio Burotto

المصدر: Clinical Pharmacology in Drug Development

مصطلحات موضوعية: atezolizumab, Adult, Male, medicine.medical_specialty, Lung Neoplasms, hyaluronanidase, Injections, Subcutaneous, Population, Urology, Locally advanced, Pharmaceutical Science, Antineoplastic Agents, NSCLC, Antibodies, Monoclonal, Humanized, 030226 pharmacology & pharmacy, 03 medical and health sciences, Dose finding, 0302 clinical medicine, Pharmacokinetics, Atezolizumab, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Pharmacology (medical), Trough Concentration, education, Lung cancer, Aged, Aged, 80 and over, education.field_of_study, Dose-Response Relationship, Drug, business.industry, Area under the curve, Articles, Janus Kinase 2, Middle Aged, medicine.disease, 030220 oncology & carcinogenesis, Original Article, subcutaneous, Female, business, pharmacokinetics

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::460eaa5bada63e718c2cb18246162513
https://doi.org/10.1002/cpdd.936

View record at Wiley

3

Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(32)

مصطلحات موضوعية: Adult, Male, Cancer Research, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Benzimidazoles, Biomarkers, Tumor, Carboplatin, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Clinical Decision-Making, Female, Gene Expression Profiling, Humans, Lung Neoplasms, Middle Aged, Neoplasm Staging, Paclitaxel, Patient Selection, Progression-Free Survival, Smokers, Time Factors, Transcriptome, Veliparib, DNA damage, medicine.medical_treatment, Squamous cell lung cancer, chemistry.chemical_compound, 80 and over, Medicine, Lung cancer, Non-Small-Cell Lung, Polymerase, Chemotherapy, Tumor, biology, business.industry, Carcinoma, medicine.disease, First line treatment, Oncology, chemistry, Squamous Cell, biology.protein, Cancer research, business, Biomarkers

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::514dc6ffd32107af8c370ecf50e3b82f
https://pubmed.ncbi.nlm.nih.gov/34436928

4

Phase 1/2a trial of nadunolimab, a first-in-class fully humanized monoclonal antibody against IL1RAP, in combination with cisplatin and gemcitabine (CG) in patients with non-small cell lung cancer (NSCLC)

المؤلفون: Astrid Paulus, Saulius Cicenas, Zanete Zvirbule, Luis G. Paz-Ares, Ahmad Awada, Ignacio Garcia-Ribas, Nedjad Losic, Marius Zemaitis

المصدر: Journal of Clinical Oncology. 40:9020-9020

مصطلحات موضوعية: Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6369ace09f31407d038cfe6703f7a7c0
https://doi.org/10.1200/jco.2022.40.16_suppl.9020

5

Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage–SCLC: Results From the Phase 3 MERU Study

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Immunoconjugates, Lung Neoplasms, Maintenance, medicine.medical_treatment, Population, Peripheral edema, DLL3, Phase 3, Antibodies, Monoclonal, Humanized, Placebo, Rovalpituzumab tesirine, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Maintenance therapy, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, education, Platinum-based chemotherapy, Platinum, Benzodiazepinones, Chemotherapy, education.field_of_study, Small cell lung cancer, business.industry, Middle Aged, Confidence interval, 3. Good health, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, medicine.symptom, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86ac72b3b5a5194730ae4d89381fe419
http://hdl.handle.net/10852/91515

6

Phase 2 study of PD-1 inhibitor JTX-4014 alone and in combination with vopratelimab, an ICOS agonist, in biomarker-selected subjects with metastatic NSCLC after one prior platinum-containing regimen (SELECT)

المصدر: Journal of Clinical Oncology. 39:TPS9137-TPS9137

مصطلحات موضوعية: Agonist, Oncology, Cancer Research, medicine.medical_specialty, biology, medicine.drug_class, business.industry, Immune checkpoint inhibitors, Phases of clinical research, Regimen, Internal medicine, Programmed cell death 1, medicine, biology.protein, Biomarker (medicine), business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::dd12a2be8c4f2cbc815ea657d4cb0a9b
https://doi.org/10.1200/jco.2021.39.15_suppl.tps9137

7

Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non–Small-Cell Lung Cancer

المؤلفون: Thomas Lowe, Filippo de Braud, Silvia Novello, C. Daniel Kingsley, Thomas Cosgriff, Tarek Mekhail, Hervé Lena, Wolfgang Schütte, See Phan, Jessie Hao-Ru Hsu, Fadi Braiteh, Heather A. Wakelee, Diego Kaen, William E. Lawler, Zanete Zvirbule, Michelle Boyer

المصدر: Clinical Lung Cancer. 18:50-59

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Lung Neoplasms, Phases of clinical research, Carboplatin, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Aged, 80 and over, education.field_of_study, Antibodies, Monoclonal, Middle Aged, Prognosis, Bevacizumab, Survival Rate, Pemetrexed, Onartuzumab, 030220 oncology & carcinogenesis, Cohort, Female, Safety, medicine.drug, Adult, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Paclitaxel, Population, Adenocarcinoma, 03 medical and health sciences, Double-Blind Method, Internal medicine, medicine, Humans, Progression-free survival, education, Lung cancer, Aged, Neoplasm Staging, business.industry, medicine.disease, Surgery, 030104 developmental biology, Cisplatin, business, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ed753a22b242aa834a1a7cb36bd62bd
https://doi.org/10.1016/j.cllc.2016.09.013

View record from ScienceDirect

Full Text via ClinicalKey

8

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial

المؤلفون: Alexandru Eniu, Günther G. Steger, Thomas Brodowicz, Bohuslav Melichar, Christoph C. Zielinski, Salomon M. Stemmer, Richard Greil, Zsuzsanna Kahán, Zanete Zvirbule, Daniela Sirbu, Tadeusz Pienkowski, Semir Beslija, Bella Nisenbaum, Rodica Anghel, Diethelm Messinger, M. Dank, Lubos Petruzelka, István Láng, Moshe Inbar

المصدر: The Lancet Oncology. 17:1230-1239

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Paclitaxel, Bevacizumab, Receptor, ErbB-2, Population, Breast Neoplasms, Capecitabine, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Neoplasm Metastasis, education, Survival rate, Aged, Neoplasm Staging, education.field_of_study, business.industry, Hazard ratio, Prognosis, medicine.disease, Interim analysis, Metastatic breast cancer, Surgery, Survival Rate, 030104 developmental biology, Tolerability, 030220 oncology & carcinogenesis, Quality of Life, Female, Neoplasm Recurrence, Local, business, Follow-Up Studies, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76f45836fc9c3d8b26bf99e10d1eafb7
https://doi.org/10.1016/s1470-2045(16)30154-1

View record from ScienceDirect

Find this article in full text from ProQuest

Full Text via ClinicalKey

9

A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study

المساهمون: Supporting clinical sciences, Experimental Pathology

المصدر: Annals of Oncology

مصطلحات موضوعية: 0301 basic medicine, Male, medicine.medical_specialty, CLDN18.2, Drug-Related Side Effects and Adverse Reactions, Esophageal Neoplasms, Nausea, gastro-oesophageal junction adenocarcinoma, Medizin, Adenocarcinoma, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Stomach Neoplasms, Internal medicine, Gastrointestinal Tumors, medicine, Humans, Progression-free survival, Aged, business.industry, Stomach, gastric cancer, Cancer, Antibodies, Monoclonal, Hematology, Original Articles, Middle Aged, medicine.disease, ddc, IMAB362, 030104 developmental biology, medicine.anatomical_structure, Treatment Outcome, Oncology, Tolerability, 030220 oncology & carcinogenesis, Cohort, Vomiting, Female, Esophagogastric Junction, medicine.symptom, zolbetuximab, Neoplasm Recurrence, Local, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6863eca11a9c4fae789ae534b4aa7775
https://mediatum.ub.tum.de/1537964

10

دورية أكاديمية

Metastatic breast cancer in patient with clinical neurofibromatosis type 1

المؤلفون: Elīna Nadziņa, Evita Gašenko, Signe Plāte, Žanete Zvirbule, Alinta Hegmane

المصدر: Current Problems in Cancer: Case Reports, Vol 10, Iss , Pp 100240- (2023)

مصطلحات موضوعية: Breast cancer, Case report, Neurofibromatosis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666621923000248; https://doaj.org/toc/2666-6219

URL الوصول: https://doaj.org/article/6a8e19f003fb4cca8149be857c930960

Full Text via ClinicalKey

Full Text Finder

تنقيح النتائج